关键词: COVID-19 Kuwait cost analysis direct medical cost economic impact

来  源:   DOI:10.2147/CEOR.S467543   PDF(Pubmed)

Abstract:
UNASSIGNED: This study aims to estimate the direct medical cost of COVID-19 hospitalizations and to utilize prevalence estimates from Jaber Al-Ahmad Hospital to estimate the direct medical cost of all hospitalized adult patients in Kuwait using a decision tree analysis.
UNASSIGNED: A cost-of-illness model was developed. The Ministry of Health perspective was considered, direct medical costs were estimated from July 1st to September 30th, using a bottom-up approach. The mean cost per hospitalized patient was estimated using a decision analysis model. Prevalence estimates of ambulance use, use of ER, ICU admission, and mortality were considered in the current study. Patients aged 18 years and above with a confirmed diagnosis of COVID-19 were included. One-way sensitivity analysis and probabilistic sensitivity analysis (PSA) were performed.
UNASSIGNED: Data for 2986 patients were analyzed. The mean age was 61 (SD= 11) years old. Most of the patients were Kuwaiti (2864, 95.91%), and more than half were females (1677, 56.16%). Of the total hospital admissions, 417 patients (14%) were admitted to the ICU. The average length of the hospital stay was 11 (SD= 9) days, and among all hospital admissions, 270 (9.04%) patients died. The total estimated direct medical cost of hospitalized patients at Jaber Al-Ahmad Hospital was $47,213,768 (14,283,203.6 KD). The average cost of hospital stay per patient was estimated at $15,498 (4,688.60 KD). The weighted average cost per hospitalized patient in Kuwait was estimated at $16,373 (4,953.08 KD). The total direct medical cost of hospitalized COVID-19 patients in Kuwait during the study period was estimated at $174,372,450 (52,751,502 KD).
UNASSIGNED: The COVID-19 pandemic constituted a significant burden on the Kuwaiti healthcare system. The findings of this study urge the need for preventive care strategies to reduce adverse health outcomes and the economic impact of the pandemic.
摘要:
本研究旨在估算COVID-19住院的直接医疗费用,并利用JaberAl-Ahmad医院的患病率估算,使用决策树分析估算科威特所有住院成年患者的直接医疗费用。
建立了疾病成本模型。考虑了卫生部的观点,直接医疗费用估计从7月1日至9月30日,使用自下而上的方法。使用决策分析模型估计每位住院患者的平均费用。救护车使用的患病率估计,使用ER,入住ICU,本研究考虑了死亡率。纳入18岁及以上确诊为COVID-19的患者。进行单向敏感性分析和概率敏感性分析(PSA)。
分析了2986例患者的数据。平均年龄61岁(SD=11)。大多数患者是科威特(2864,95.91%),一半以上是女性(1677,56.16%)。在住院总人数中,417名患者(14%)进入ICU。平均住院时间为11(SD=9)天,在所有住院患者中,270例(9.04%)患者死亡。JaberAl-Ahmad医院住院患者的估计直接医疗费用总额为47,213,768美元(14,283,203.6KD)。每位患者的平均住院费用估计为$15,498(4,688.60KD)。科威特每名住院患者的加权平均费用估计为16373美元(4953.08KD)。在研究期间,科威特住院的COVID-19患者的总直接医疗费用估计为174,372,450美元(52,751,502KD)。
COVID-19大流行对科威特医疗保健系统构成了重大负担。这项研究的结果敦促需要预防性护理策略,以减少不良健康结果和大流行的经济影响。
公众号